Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
130 hedge funds and large institutions have $40.7M invested in Sanofi Contingent Value Rights in 2013 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 31 closing their positions.
4% less funds holding
Funds holding: 136 → 130 (-6)
16% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 31
25% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 32
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
88% less capital invested
Capital invested by funds: $338M → $40.7M (-$297M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
+$11.4M |
| 2 |
CPM
Chesapeake Partners Management
Baltimore,
Maryland
|
+$5.44M |
| 3 |
MCM
Mason Capital Management
New York
|
+$4.18M |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$3.63M |
| 5 |
SI
Standard Investments
New York
|
+$2.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DI
Dalton Investments
Las Vegas,
Nevada
|
-$34M |
| 2 |
SC
Sculptor Capital
New York
|
-$24.1M |
| 3 |
ACM
Abrams Capital Management
Boston,
Massachusetts
|
-$23.6M |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$13.2M |
| 5 |
AAA
Alpine Associates Advisors
Englewood Cliffs,
New Jersey
|
-$10.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FCH
126
Freestone Capital Holdings
Seattle,
Washington
| – | -$54K | -31,885 | Closed |
|
127
Bank of New York Mellon
New York
| – | -$21K | -10,522 | Closed |
|
|
TCM
128
Touradji Capital Management
Boca Raton,
Florida
| – | -$20K | -10,000 | Closed |
|
|
WA
129
WealthTrust-Arizona
Scottsdale,
Arizona
| – | -$2K | -800 | Closed |
|
|
FFC
130
First Financial Corp
Terre Haute,
Indiana
| – | -$1K | -300 | Closed |
|
131
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$25 | -21 | -4% |
|
|
PIM
132
Parasol Investment Management
Westmont,
Illinois
| – | +$11 | +9 | New |
|
|
CHC
133
City Holding Co
Charleston,
West Virginia
| – | +$88 | +73 | New |
|
|
CLOS
134
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | +$102 | +84 | New |
|
|
GHAM
135
Gilman Hill Asset Management
New Canaan,
Connecticut
| – | +$140 | +116 | New |
|
|
PFSC
136
Peoples Financial Services Corp
Dunmore,
Pennsylvania
| – | +$181 | +150 | New |
|
|
WEC
137
Winslow Evans & Crocker
Boston,
Massachusetts
| – | +$636 | +526 | New |
|
GCVRZ Hedge Fund Activity: Q4 2013 in Review
130 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2013, worth a combined $40.7M — down 88% from $338M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of GCVRZ and 26 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 24 added.
The largest buyer was Fir Tree Capital Management, adding an estimated $11.4M. The largest seller was Dalton Investments, exiting entirely with an estimated $34M sold.
- 130 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2013, down from 136 in Q3 2013.
- Funds reported $40.7M of Sanofi Contingent Value Rights stock for Q4 2013, down 88% quarter-over-quarter.
- 26 funds opened new Sanofi Contingent Value Rights positions in Q4 2013 and 31 closed out, a net change of -5 holders.
- The largest Sanofi Contingent Value Rights buyer in Q4 2013 was Fir Tree Capital Management, an estimated $11.4M added.
- The largest Sanofi Contingent Value Rights seller in Q4 2013 was Dalton Investments, an estimated $34M sold.
Based on aggregated 13F filings for Q4 2013.